Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Searle

Showing results (231-240 of 268) with videos related to

Pageof 27
Sort By:
Nucleic Acids Research|October 11, 1990
Expression of a human O6-alkylguanine-DNA-alkyltransferase cDNA in human cells and transgenic miceC Y Fan, P M Potter, J Rafferty, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|December 25, 2025
Playing the long game: virtual reality training for standard precautions in long-term careMichelle S Jerry, Vianelly V García, Andrea S Greenfield, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 2006
Interferon-gamma inhibits extravillous trophoblast cell invasion by a mechanism that involves both changes in apoptosis and protease levelsGendie E Lash, Harry A Otun, Barbara A Innes, et al.
FEBS Letters|June 1, 2022
The 3D-structure, kinetics and dynamics of the E. coli nitroreductase NfsA with NADP<sup>+</sup> provide glimpses of its catalytic mechanismScott A White, Andrew J Christofferson, Alastair I Grainger, et al.
Gene Therapy|May 18, 1999
Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954I A McNeish, N K Green, M G Gilligan, et al.
Gene Therapy|May 28, 2004
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vectorM-J Chen, N K Green, G M Reynolds, et al.
British Journal of Cancer|November 1, 1988
Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin AJ A Ledermann, R H Begent, K D Bagshawe, et al.
The Journal of Biological Chemistry|February 3, 2005
Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone. Reversed binding orientations in different redox states of the enzymePaul R Race, Andrew L Lovering, Richard M Green, et al.
Cancer Research|September 23, 2003
Generation of Escherichia coli nitroreductase mutants conferring improved cell sensitization to the prodrug CB1954Jane I Grove, Andrew L Lovering, Christopher Guise, et al.
Placenta|May 21, 2010
Role of interleukin 8 in uterine natural killer cell regulation of extravillous trophoblast cell invasionL G De Oliveira, G E Lash, C Murray-Dunning, et al.
Pageof 27

Showing results (231-240 of 268) with videos related to

Sort By:
Pageof 27
Nucleic Acids Research|October 11, 1990
Expression of a human O6-alkylguanine-DNA-alkyltransferase cDNA in human cells and transgenic miceC Y Fan, P M Potter, J Rafferty, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|December 25, 2025
Playing the long game: virtual reality training for standard precautions in long-term careMichelle S Jerry, Vianelly V García, Andrea S Greenfield, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 2006
Interferon-gamma inhibits extravillous trophoblast cell invasion by a mechanism that involves both changes in apoptosis and protease levelsGendie E Lash, Harry A Otun, Barbara A Innes, et al.
FEBS Letters|June 1, 2022
The 3D-structure, kinetics and dynamics of the E. coli nitroreductase NfsA with NADP<sup>+</sup> provide glimpses of its catalytic mechanismScott A White, Andrew J Christofferson, Alastair I Grainger, et al.
Gene Therapy|May 18, 1999
Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954I A McNeish, N K Green, M G Gilligan, et al.
Gene Therapy|May 28, 2004
Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vectorM-J Chen, N K Green, G M Reynolds, et al.
British Journal of Cancer|November 1, 1988
Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin AJ A Ledermann, R H Begent, K D Bagshawe, et al.
The Journal of Biological Chemistry|February 3, 2005
Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone. Reversed binding orientations in different redox states of the enzymePaul R Race, Andrew L Lovering, Richard M Green, et al.
Cancer Research|September 23, 2003
Generation of Escherichia coli nitroreductase mutants conferring improved cell sensitization to the prodrug CB1954Jane I Grove, Andrew L Lovering, Christopher Guise, et al.
Placenta|May 21, 2010
Role of interleukin 8 in uterine natural killer cell regulation of extravillous trophoblast cell invasionL G De Oliveira, G E Lash, C Murray-Dunning, et al.
Pageof 27